β-amyloid precursor protein (β-APP) and Presenilin 1 (PS1) play important roles in AD [16], as each of these proteins significantly accelerates the rate of decline in cognitive function, which in turn leads to an accelerated AD clinical course [17]. This evidence concerns the gene PSEN1 and Alzheimer disease.